Torsten Goesch M.D Ph.D
Board Member

Dr. Torsten Goesch has been the director of Rosetta Capital secondary life science investor since 2002, where he is responsible for the management of several Rosetta Capital investments and has served on several biotech company boards including Enobia Ltd and Cytochroma Ltd. Dr. Goesch is also founder and former Managing Director of TRG Invest, a Munich-based consulting business providing companies in the life science sector. Additionally, Dr. Goesch served as the General Manager for the German-Speaking Countries at Biogen from 1997-1999, and before that he served as the Commercial Head of Merck KGaA’s worldwide generics drug business Merck Generics. He practiced as a doctor of internal medicine at the University Hospital Hamburg-Eppendorf from 1988-1990, focusing on nephrology, immunology and oncology.